TABLE 1.
Baseline demographic and clinical characteristics of patients with rosacea
| Variable | Phase 3 full analysis set (N = 130) |
|---|---|
| Men, n (%) | 23 (17.7) |
| Age, years | |
| Range, n (%) | |
| <20 | 0 |
| ≧20 to <30 | 6 (4.6) |
| ≧30 to<40 | 25 (19.2) |
| ≧40 to <50 | 54 (41.5) |
| ≧50 to <60 | 23 (17.7) |
| ≧60 to <70 | 12 (9.2) |
| ≧70 to <80 | 7 (5.4) |
| ≧80 | 3 (2.3) |
| Mean (SD) | 47.8 (13.0) |
| Rosacea timeline, years, mean (SD) a | |
| Age of onset | 43.8 (14.3) |
| Duration | 4.7 (6.8) |
| Associated medical conditions in >5% of patients, n (%) | |
| Seasonal allergy (pollen) | 35 (26.9) |
| Hypertension | 15 (11.5) |
| Constipation | 9 (6.9) |
| Hyperuricemia | 9 (6.9) |
| Insomnia | 9 (6.9) |
| Migraine | 9 (6.9) |
| Allergic rhinitis | 8 (6.2) |
| Urticaria | 8 (6.2) |
Abbreviation: SD, standard deviation.
a
Data were available for 121 of 130 patients.